News

ViridiScreen® in first active trial on a nuclear site

ViridiScreen a sensitive and, importantly, robust alpha detection system, which uses the measurement of photons derived from the interaction of alpha particles with nitrogen in the air, to determine the gross alpha activity on a surface

  • Posted On: 30 July 2018
ViridiScreen® in first active trial on a nuclear site


Feedback from the successful trial was very positive, with stakeholders saying that the very simple design had the advantage to potentially be tweaked, making it smaller or sacrificial.  ViridiScreen’s simplicity of design and output could be an advantage for very specific scenarios, such as monitoring inside scaffolding poles, where size is critical.
Categories: News
Tags: